27 May 2013
Keywords: kowa, nikken, co-promote, olmesartan, medoxomil, japanese, firms
Article | 02 February 2004
Japanese firms Kowa and Nikken Chemicals have reached an agreement to co-promote olmesartan medoxmil, a new hypertension drug, for which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.